Literature DB >> 9512515

Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes.

M Woo1, R Hakem, M S Soengas, G S Duncan, A Shahinian, D Kägi, A Hakem, M McCurrach, W Khoo, S A Kaufman, G Senaldi, T Howard, S W Lowe, T W Mak.   

Abstract

Caspases are fundamental components of the mammalian apoptotic machinery, but the precise contribution of individual caspases is controversial. CPP32 (caspase 3) is a prototypical caspase that becomes activated during apoptosis. In this study, we took a comprehensive approach to examining the role of CPP32 in apoptosis using mice, embryonic stem (ES) cells, and mouse embryonic fibroblasts (MEFs) deficient for CPP32. CPP32(ex3-/-) mice have reduced viability and, consistent with an earlier report, display defective neuronal apoptosis and neurological defects. Inactivation of CPP32 dramatically reduces apoptosis in diverse settings, including activation-induced cell death (AICD) of peripheral T cells, as well as chemotherapy-induced apoptosis of oncogenically transformed CPP32(-/-) MEFs. As well, the requirement for CPP32 can be remarkably stimulus-dependent: In ES cells, CPP32 is necessary for efficient apoptosis following UV- but not gamma-irradiation. Conversely, the same stimulus can show a tissue-specific dependence on CPP32: Hence, TNFalpha treatment induces normal levels of apoptosis in CPP32 deficient thymocytes, but defective apoptosis in oncogenically transformed MEFs. Finally, in some settings, CPP32 is required for certain apoptotic events but not others: Select CPP32(ex3-/-) cell types undergoing cell death are incapable of chromatin condensation and DNA degradation, but display other hallmarks of apoptosis. Together, these results indicate that CPP32 is an essential component in apoptotic events that is remarkably system- and stimulus-dependent. Consequently, drugs that inhibit CPP32 may preferentially disrupt specific forms of cell death.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9512515      PMCID: PMC316633          DOI: 10.1101/gad.12.6.806

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  56 in total

1.  The Caenorhabditis elegans cell-death protein CED-3 is a cysteine protease with substrate specificities similar to those of the human CPP32 protease.

Authors:  D Xue; S Shaham; H R Horvitz
Journal:  Genes Dev       Date:  1996-05-01       Impact factor: 11.361

Review 2.  The molecular biology of apoptosis.

Authors:  D L Vaux; A Strasser
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

3.  p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches.

Authors:  S Lee; B Elenbaas; A Levine; J Griffith
Journal:  Cell       Date:  1995-06-30       Impact factor: 41.582

Review 4.  The killer and the executioner: how apoptosis controls malignancy.

Authors:  D R Green; S J Martin
Journal:  Curr Opin Immunol       Date:  1995-10       Impact factor: 7.486

Review 5.  Apoptosis in the pathogenesis and treatment of disease.

Authors:  C B Thompson
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

6.  Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis.

Authors:  D W Nicholson; A Ali; N A Thornberry; J P Vaillancourt; C K Ding; M Gallant; Y Gareau; P R Griffin; M Labelle; Y A Lazebnik
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

7.  Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages.

Authors:  V A Fadok; D R Voelker; P A Campbell; J J Cohen; D L Bratton; P M Henson
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

8.  Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours.

Authors:  T G Graeber; C Osmanian; T Jacks; D E Housman; C J Koch; S W Lowe; A J Giaccia
Journal:  Nature       Date:  1996-01-04       Impact factor: 49.962

9.  Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B.

Authors:  A J Darmon; D W Nicholson; R C Bleackley
Journal:  Nature       Date:  1995-10-05       Impact factor: 49.962

10.  Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death.

Authors:  L Casciola-Rosen; D W Nicholson; T Chong; K R Rowan; N A Thornberry; D K Miller; A Rosen
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  174 in total

1.  Role of factors downstream of caspases in nuclear disassembly during apoptotic execution.

Authors:  K Samejima; P Villa; W C Earnshaw
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-09-29       Impact factor: 6.237

Review 2.  The role of apoptosis in normal and abnormal embryonic development.

Authors:  A Brill; A Torchinsky; H Carp; V Toder
Journal:  J Assist Reprod Genet       Date:  1999-11       Impact factor: 3.412

3.  NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis.

Authors:  C Y Wang; D C Guttridge; M W Mayo; A S Baldwin
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

4.  Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis.

Authors:  M Mancini; C E Machamer; S Roy; D W Nicholson; N A Thornberry; L A Casciola-Rosen; A Rosen
Journal:  J Cell Biol       Date:  2000-05-01       Impact factor: 10.539

5.  Thymocyte apoptosis.

Authors:  Y Yang; J D Ashwell
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

6.  Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases.

Authors:  J T Finn; M Weil; F Archer; R Siman; A Srinivasan; M C Raff
Journal:  J Neurosci       Date:  2000-02-15       Impact factor: 6.167

7.  Caspase cleavage of MST1 promotes nuclear translocation and chromatin condensation.

Authors:  S Ura; N Masuyama; J D Graves; Y Gotoh
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

8.  Focusing forward genetics: a tripartite ENU screen for neurodevelopmental mutations in the mouse.

Authors:  R W Stottmann; J L Moran; A Turbe-Doan; E Driver; M Kelley; D R Beier
Journal:  Genetics       Date:  2011-04-21       Impact factor: 4.562

Review 9.  Insights into T-cell development from studies using transgenic and knockout mice.

Authors:  M A Basson; R Zamoyska
Journal:  Mol Biotechnol       Date:  2001-05       Impact factor: 2.695

Review 10.  Molecular mechanisms of nitrogen dioxide induced epithelial injury in the lung.

Authors:  Rebecca L Persinger; Matthew E Poynter; Karna Ckless; Yvonne M W Janssen-Heininger
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.